Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides

Abstract

A major challenge for the application of peptide therapeutics is their short half-lifein vivo. Here, the authors design peptide-fatty acid chimeras bearing an engineered linker that promotes albumin binding and allows longer circulation times of therapeutic peptides in animal models.